回复：原发性乳腺癌术前短期内分泌治疗后Ki67表达的预后价值 - Suppr

Suppr

超能文献

Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

作者信息

Hrushesky William J M, Retsky Michael, Baum Michael, Demicheli Romano

出版信息

J Natl Cancer Inst. 2007 Jul 4;99(13):1053; author reply 1053-4. doi: 10.1093/jnci/djm019. Epub 2007 Jun 27.

DOI:10.1093/jnci/djm019

PMID:17596578

Abstract

摘要

相似文献

Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

J Natl Cancer Inst. 2007 Jul 4;99(13):1053; author reply 1053-4. doi: 10.1093/jnci/djm019. Epub 2007 Jun 27.

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

J Natl Cancer Inst. 2007 Jan 17;99(2):167-70. doi: 10.1093/jnci/djk020.

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23.

Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1024s-1030s. doi: 10.1158/1078-0432.CCR-05-2127.

Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.

J Clin Oncol. 2008 Mar 20;26(9):1404-10. doi: 10.1200/JCO.2007.10.6393.

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

J Natl Cancer Inst. 2008 Feb 6;100(3):207-12. doi: 10.1093/jnci/djm289. Epub 2008 Jan 29.

Adjuvant hormonal therapy for premenopausal women with breast cancer.

Semin Oncol. 2006 Dec;33(6):657-63. doi: 10.1053/j.seminoncol.2006.08.014.

A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Breast Cancer Res. 2008;10(5):R88. doi: 10.1186/bcr2158. Epub 2008 Oct 17.

Do biomarker changes during neoadjuvant endocrine therapy reflect breast tumor receptor status?

Nat Clin Pract Oncol. 2005 Oct;2(10):498-9. doi: 10.1038/ncponc0298.

Neoadjuvant endocrine therapy for locally advanced breast cancer.

Semin Oncol. 2006 Dec;33(6):650-6. doi: 10.1053/j.seminoncol.2006.08.013.

引用本文的文献

Correlation between the Expression of Topo IIα and Ki67 in breast cancer and its clinical Pathological characteristics.

Pak J Med Sci. 2017 Jul-Aug;33(4):844-848. doi: 10.12669/pjms.334.13143.

Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia.

Leuk Res. 2010 Oct;34(10):1320-4. doi: 10.1016/j.leukres.2010.03.010. Epub 2010 Apr 1.

Development of a bioassay to monitor circulating plasma Ki-67.

Leuk Res. 2010 Jul;34(7):848-9. doi: 10.1016/j.leukres.2010.01.007. Epub 2010 Feb 20.

Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.

Leuk Res. 2010 Feb;34(2):173-6. doi: 10.1016/j.leukres.2009.07.030. Epub 2009 Aug 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

作者信息

Hrushesky William J M, Retsky Michael, Baum Michael, Demicheli Romano

出版信息

J Natl Cancer Inst. 2007 Jul 4;99(13):1053; author reply 1053-4. doi: 10.1093/jnci/djm019. Epub 2007 Jun 27.

DOI:10.1093/jnci/djm019

PMID:17596578

Abstract

摘要

相似文献

Re: Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

J Natl Cancer Inst. 2007 Jul 4;99(13):1053; author reply 1053-4. doi: 10.1093/jnci/djm019. Epub 2007 Jun 27.

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

J Natl Cancer Inst. 2007 Jan 17;99(2):167-70. doi: 10.1093/jnci/djk020.

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.

J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8. doi: 10.1093/jnci/djn309. Epub 2008 Sep 23.

Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1024s-1030s. doi: 10.1158/1078-0432.CCR-05-2127.

J Clin Oncol. 2008 Mar 20;26(9):1404-10. doi: 10.1200/JCO.2007.10.6393.

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

J Natl Cancer Inst. 2008 Feb 6;100(3):207-12. doi: 10.1093/jnci/djm289. Epub 2008 Jan 29.

Adjuvant hormonal therapy for premenopausal women with breast cancer.

Semin Oncol. 2006 Dec;33(6):657-63. doi: 10.1053/j.seminoncol.2006.08.014.

A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

Breast Cancer Res. 2008;10(5):R88. doi: 10.1186/bcr2158. Epub 2008 Oct 17.

Do biomarker changes during neoadjuvant endocrine therapy reflect breast tumor receptor status?

Nat Clin Pract Oncol. 2005 Oct;2(10):498-9. doi: 10.1038/ncponc0298.

Neoadjuvant endocrine therapy for locally advanced breast cancer.

Semin Oncol. 2006 Dec;33(6):650-6. doi: 10.1053/j.seminoncol.2006.08.013.

引用本文的文献

Correlation between the Expression of Topo IIα and Ki67 in breast cancer and its clinical Pathological characteristics.

Pak J Med Sci. 2017 Jul-Aug;33(4):844-848. doi: 10.12669/pjms.334.13143.

Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia.

Leuk Res. 2010 Oct;34(10):1320-4. doi: 10.1016/j.leukres.2010.03.010. Epub 2010 Apr 1.

Development of a bioassay to monitor circulating plasma Ki-67.

Leuk Res. 2010 Jul;34(7):848-9. doi: 10.1016/j.leukres.2010.01.007. Epub 2010 Feb 20.

Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.

Leuk Res. 2010 Feb;34(2):173-6. doi: 10.1016/j.leukres.2009.07.030. Epub 2009 Aug 12.